Sumitomo Dainippon Pharma Co., Ltd., operates every day to achieve its corporate mission "to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide." By pouring all our efforts into the research and development of new drugs, we aim to provide innovative and valuable pharmaceutical solutions to people not only in Japan but also around the world in order to realize our corporate mission.

We will remain committed to research and development by taking every available opportunity to assimilate cutting-edge technologies through combinations of a wide variety of avenues, including in-house research, technology in-licensing, and joint research with academia and biotech companies, with the aim of continually discovering excellent pharmaceutical products in our focus research areas of Psychiatry & Neurology, Oncology, and Regenerative Medicine & Cell Therapy. Furthermore, we will explore new businesses in the healthcare sector and offer solutions other than treatment by pharmaceutical products in order to gain opportunities to contribute to the well-being of people through the use of digital technologies and other methods.